By utilizing this uniqueendocytosis pathway, here we create a biologically inspired nanostructure that caninduce cancer cells to ‘drink drugs' for targeting activatingtranscription factor-5 (ATF5), an overexpressed anti-apoptotic transcription factorin glioblastoma. Here, ATF5 is linked to glioblastoma.